A citation-based method for searching scientific literature

Claudio Fiocchi, Gabriele Dragoni, Dimitrios Iliopoulos, Konstantinos Katsanos, Vicent Hernandez Ramirez, Kohei Suzuki. J Crohns Colitis 2021
Times Cited: 7







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Jason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, Melanie Schirmer, Julian Avila-Pacheco, Tiffany W Poon, Elizabeth Andrews, Nadim J Ajami, Kevin S Bonham, Colin J Brislawn,[...]. Nature 2019
549
42

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber,[...]. Nat Med 2017
286
42

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante. EBioMedicine 2019
50
42

Long-term evolution of disease behavior of Crohn's disease.
Jacques Cosnes, Stéphane Cattan, Antoine Blain, Laurent Beaugerie, Franck Carbonnel, Rolland Parc, Jean-Pierre Gendre. Inflamm Bowel Dis 2002
888
28

Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
James D Lewis, Maria T Abreu. Gastroenterology 2017
138
28

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne,[...]. Lancet 2017
362
28

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis.
R S Choung, F Princen, T P Stockfisch, J Torres, A C Maue, C K Porter, F Leon, B De Vroey, S Singh, M S Riddle,[...]. Aliment Pharmacol Ther 2016
57
28

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.
Johan Burisch, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D'Incà,[...]. Gut 2019
85
28

Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
Williams Turpin, Sun-Ho Lee, Juan Antonio Raygoza Garay, Karen L Madsen, Jonathan B Meddings, Larbi Bedrani, Namita Power, Osvaldo Espin-Garcia, Wei Xu, Michelle I Smith,[...]. Gastroenterology 2020
35
28

Differential effect of genetic burden on disease phenotypes in Crohn's disease and ulcerative colitis: analysis of a North American cohort.
Ashwin N Ananthakrishnan, Hailiang Huang, Deanna D Nguyen, Jenny Sauk, Vijay Yajnik, Ramnik J Xavier. Am J Gastroenterol 2014
64
28

Early intervention in Crohn's disease: towards disease modification trials.
Silvio Danese, Gionata Fiorino, Laurent Peyrin-Biroulet. Gut 2017
54
28

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
28

Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Joana Torres, Francesca Petralia, Takahiro Sato, Pei Wang, Shannon E Telesco, Rok Seon Choung, Richard Strauss, Xiao-Jun Li, Renee M Laird, Ramiro L Gutierrez,[...]. Gastroenterology 2020
36
28

Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.
Joana Torres, Johan Burisch, Mark Riddle, Marla Dubinsky, Jean-Frédéric Colombel. Gut 2016
43
28

Evolving therapeutic goals in ulcerative colitis: towards disease clearance.
Silvio Danese, Giulia Roda, Laurent Peyrin-Biroulet. Nat Rev Gastroenterol Hepatol 2020
32
28

Ulcerative colitis as a progressive disease: the forgotten evidence.
Joana Torres, Vincent Billioud, David B Sachar, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Inflamm Bowel Dis 2012
119
28

Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
Bram Verstockt, Nurulamin M Noor, Urko M Marigorta, Polychronis Pavlidis, Parakkal Deepak, Ryan C Ungaro. J Crohns Colitis 2021
5
40


What's new in IBD therapy: An "omics network" approach.
Claudio Fiocchi, Dimitrios Iliopoulos. Pharmacol Res 2020
11
28

Personalised medicine in Crohn's disease.
Nurulamin M Noor, Bram Verstockt, Miles Parkes, James C Lee. Lancet Gastroenterol Hepatol 2020
19
28

Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
Bram Verstockt, Sare Verstockt, Brecht Creyns, Sophie Tops, Gert Van Assche, Ann Gils, Jan L Ceuppens, Séverine Vermeire, Marc Ferrante, Christine Breynaert. Aliment Pharmacol Ther 2019
29
28

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
183
28

Predictors of Crohn's disease.
Laurent Beaugerie, Philippe Seksik, Isabelle Nion-Larmurier, Jean-Pierre Gendre, Jacques Cosnes. Gastroenterology 2006
599
28

Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.
Inger Camilla Solberg, Morten H Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum, Idar Lygren. Clin Gastroenterol Hepatol 2007
466
28

Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.
Dion Wintjens, Francois Bergey, Edoardo Saccenti, Steven Jeuring, Tim van den Heuvel, Mariëlle Romberg-Camps, Liekele Oostenbrug, Ad Masclee, Vitor Martins Dos Santos, Daisy Jonkers,[...]. J Crohns Colitis 2021
6
33

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.
Xavier Roblin, Nicolas Williet, Gilles Boschetti, Jean-Marc Phelip, Emilie Del Tedesco, Anne-Emmanuelle Berger, Philippe Vedrines, Gerard Duru, Laurent Peyrin-Biroulet, Stéphane Nancey,[...]. Gut 2020
36
28

Breaking the therapeutic ceiling in drug development in ulcerative colitis.
Dahham Alsoud, Bram Verstockt, Claudio Fiocchi, Séverine Vermeire. Lancet Gastroenterol Hepatol 2021
4
50


Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis.
Johannan F Brandse, Gijs R van den Brink, Manon E Wildenberg, Desiree van der Kleij, Theo Rispens, Jeroen M Jansen, Ron A Mathôt, Cyriel Y Ponsioen, Mark Löwenberg, Geert R A M D'Haens. Gastroenterology 2015
239
28

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Vera Ballet, Griet Compernolle, Kristel Van Steen, Steven Simoens, Paul Rutgeerts, Ann Gils, Séverine Vermeire. Gastroenterology 2015
524
28

A blood-based prognostic biomarker in IBD.
Daniele Biasci, James C Lee, Nurulamin M Noor, Diana R Pombal, Monica Hou, Nina Lewis, Tariq Ahmad, Ailsa Hart, Miles Parkes, Eoin F McKinney,[...]. Gut 2019
58
28

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
Joana Torres, Flavio Caprioli, Konstantinos H Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C Lee, James O Lindsay, David T Rubin,[...]. J Crohns Colitis 2016
65
28

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager,[...]. J Crohns Colitis 2020
207
28

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.
Suk-Kyun Yang, Myunghee Hong, Jiwon Baek, Hyunchul Choi, Wanting Zhao, Yusun Jung, Talin Haritunians, Byong Duk Ye, Kyung-Jo Kim, Sang Hyoung Park,[...]. Nat Genet 2014
275
28

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Aleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, Graham A Heap, Daniel L Rice, Mark Reppell, Claire M Bewshea, Neil Chanchlani, Gareth J Walker, Mandy H Perry,[...]. Gastroenterology 2020
86
28

Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Jerome C Martin, Christie Chang, Gilles Boschetti, Ryan Ungaro, Mamta Giri, John A Grout, Kyle Gettler, Ling-Shiang Chuang, Shikha Nayar, Alexander J Greenstein,[...]. Cell 2019
162
28

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, Leonard Baidoo, Brian Bressler, Shane M Devlin,[...]. Clin Gastroenterol Hepatol 2019
98
28

Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.
Hamed Khalili, Åsa H Everhov, Jonas Halfvarson, Jonas F Ludvigsson, Johan Askling, Pär Myrelid, Jonas Söderling, Ola Olen, Martin Neovius. Aliment Pharmacol Ther 2020
10
14

Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.
Nienke Z Borren, Grace Conway, John J Garber, Hamed Khalili, Shrish Budree, Himel Mallick, Vijay Yajnik, Ramnik J Xavier, Ashwin N Ananthakrishnan. J Crohns Colitis 2018
13
14

Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study.
Jorrit L Opstelten, Rob M J Beelen, Max Leenders, Gerard Hoek, Bert Brunekreef, Fiona D M van Schaik, Peter D Siersema, Kirsten T Eriksen, Ole Raaschou-Nielsen, Anne Tjønneland,[...]. Dig Dis Sci 2016
19
14

Characteristics and Progression of Preclinical Inflammatory Bowel Disease.
Iago Rodríguez-Lago, Olga Merino, Irene Azagra, Ainara Maiz, Eva Zapata, Rebeca Higuera, Isabel Montalvo, María Fernández-Calderón, Paz Arreba, Juan Carrascosa,[...]. Clin Gastroenterol Hepatol 2018
16
14

Changing the landscape for type 1 diabetes: the first step to prevention.
Colin M Dayan, Maria Korah, Danijela Tatovic, Brian N Bundy, Kevan C Herold. Lancet 2019
27
14



Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis.
L Xu, P Lochhead, Y Ko, B Claggett, R W Leong, A N Ananthakrishnan. Aliment Pharmacol Ther 2017
59
14

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
Shiho Takashima, Jun Kato, Sakiko Hiraoka, Asuka Nakarai, Daisuke Takei, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Hiroyuki Okada,[...]. Am J Gastroenterol 2015
69
14

Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study
Eric I Benchimol, Gilaad G Kaplan, Anthony R Otley, Geoffrey C Nguyen, Fox E Underwood, Astrid Guttmann, Jennifer L Jones, Beth K Potter, Christina A Catley, Zoann J Nugent,[...]. Am J Gastroenterol 2017
46
14

Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.
Massimo Montalto, Valentina Curigliano, Luca Santoro, Alessandro Armuzzi, Giovanni Cammarota, Marcello Covino, Maria C Mentella, Francesca Ancarani, Raffaele Manna, Antonio Gasbarrini,[...]. Am J Gastroenterol 2007
28
14

Clinical patterns of familial inflammatory bowel disease.
J Satsangi, C Grootscholten, H Holt, D P Jewell. Gut 1996
169
14

Genetic and shared environmental risk factors do not lead to eosinophil activation in healthy twins of IBD patients.
Jonas Halfvarson, Maria Ling Lundström, Maria Lampinen, Ida Schoultz, Lennart Bodin, Marie Carlson. Scand J Gastroenterol 2020
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.